BCM
AMGN icon

Brasada Capital Management’s Amgen AMGN Stock Holding History

Brasada Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,500
Closed -$711K – 136
2024
Q1 		$711K Buy
2,500
+500
+25% +$146K 0.13% 112
2023
Q4 		$576K Buy
+2,000
New +$545K 0.11% 112
2019
Q1 		– Sell
-104
Closed -$20K – 161
2018
Q4 		$20K Sell
104
-24
-19% -$4.68K 0.01% 211
2018
Q3 		$27K Sell
128
-422
-77% -$83.2K 0.01% 232
2018
Q2 		$102K Hold
550
– – 0.03% 183
2018
Q1 		$93K Hold
550
– – 0.03% 174
2017
Q4 		$96K Buy
+550
New +$97.3K 0.03% 164

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brasada Capital Management's AMGN Position: Q2 2024 in Review

Brasada Capital Management sold out of Amgen (AMGN) in Q2 2024, closing a stake of 2,500 shares — an estimated $711K sold.

Brasada Capital Management first reported a position in AMGN in Q4 2017 and held it in 7 quarters. The position peaked at $711K in Q1 2024. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Brasada Capital Management reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Brasada Capital Management sold 2,500 Amgen shares in Q2 2024, an estimated $711K.
  • Brasada Capital Management first reported a position in Amgen in Q4 2017 and held it in 7 quarters.
  • Brasada Capital Management's Amgen position peaked at $711K in Q1 2024.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Brasada Capital Management's 13F filing for Q2 2024, filed 7 Aug 2024.